Caxton Associates (New York)’s Wyndham Hotels & Resorts WH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$1.35M Sell
13,359
-16,621
-55% -$1.54M 0.04% 168
2024
Q3
$2.34M Buy
29,980
+22,191
+285% +$1.68M 0.09% 97
2024
Q2
$576K Sell
7,789
-585
-7% -$42.1K 0.02% 325
2024
Q1
$643K Sell
8,374
-2,058
-20% -$162K 0.04% 291
2023
Q4
$839K Buy
10,432
+7,357
+239% +$553K 0.04% 252
2023
Q3
$214K Sell
3,075
-14,739
-83% -$1.09M 0.03% 352
2023
Q2
$1.22M Sell
17,814
-1,580
-8% -$108K 0.18% 121
2023
Q1
$1.32M Buy
19,394
+13,359
+221% +$984K 0.2% 103
2022
Q4
$430K Sell
6,035
-11,500
-66% -$813K 0.03% 267
2022
Q3
$1.08M Buy
+17,535
New +$1.17M 0.14% 96
2022
Q2
Sell
-8,431
Closed -$714K 759
2022
Q1
$714K Buy
8,431
+3,904
+86% +$332K 0.06% 163
2021
Q4
$406K Buy
+4,527
New +$378K 0.04% 329

Other funds holding WH

Caxton Associates (New York)'s WH Position: Q4 2024 in Review

Caxton Associates (New York) reduced its Wyndham Hotels & Resorts (WH) stake by 55% in Q4 2024, selling an estimated $1.54M and leaving 13,359 shares worth $1.35M. The position accounts for 0.04% of the portfolio, ranked #168.

Caxton Associates (New York) first reported a position in WH in Q4 2021 and has held it in 12 quarters since. The position peaked at $2.34M in Q3 2024. 418 funds tracked by Wall St. Rank hold WH as of Q4 2024.

  • Caxton Associates (New York) held 13,359 shares of Wyndham Hotels & Resorts worth $1.35M as of Q4 2024.
  • Caxton Associates (New York) sold 16,621 Wyndham Hotels & Resorts shares in Q4 2024, an estimated $1.54M.
  • Wyndham Hotels & Resorts made up 0.04% of Caxton Associates (New York)'s portfolio in Q4 2024, its #168 holding.
  • Caxton Associates (New York) first reported a position in Wyndham Hotels & Resorts in Q4 2021 and has held it in 12 quarters since.
  • Caxton Associates (New York)'s Wyndham Hotels & Resorts position peaked at $2.34M in Q3 2024.
  • 418 funds tracked by Wall St. Rank held Wyndham Hotels & Resorts as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.